Welcome to our dedicated page for Regency Centers SEC filings (Ticker: REGCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Regency Centers's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Regency Centers's regulatory disclosures and financial reporting.
Morgan Stanley Smith Barney LLC submitted a Rule 144 notice reporting a sale of 10,000 shares of Common Stock by Martin E. Stein Jr. on 02/20/2026. The filing lists proceeds of $763,001 for the reported sale.
Morgan Stanley Smith Barney LLC submitted a Rule 144 notice reporting a sale of 10,000 shares of Common Stock by Martin E. Stein Jr. on 02/20/2026. The filing lists proceeds of $763,001 for the reported sale.
Martin E. Stein Jr. submitted a Form 144 notice to sell 157,892 shares of Common (identified as Founder Stock) for cash. The filing is dated 05/04/2026.
The filing also reports 10,000 shares sold on 02/20/2026 for $763,001.00 as prior sales within the three-month lookback.
Martin E. Stein Jr. submitted a Form 144 notice to sell 157,892 shares of Common (identified as Founder Stock) for cash. The filing is dated 05/04/2026.
The filing also reports 10,000 shares sold on 02/20/2026 for $763,001.00 as prior sales within the three-month lookback.
Martin E. Stein Jr. filed a Form 144 reporting the sale of 10,000 shares of Common stock on 02/20/2026 for $763,001. The notice lists the transaction under Rule 144 resale procedures and identifies the broker as Morgan Stanley Smith Barney LLC.
Martin E. Stein Jr. filed a Form 144 reporting the sale of 10,000 shares of Common stock on 02/20/2026 for $763,001. The notice lists the transaction under Rule 144 resale procedures and identifies the broker as Morgan Stanley Smith Barney LLC.
Regency Centers Corp: Vanguard Capital Management reported beneficial ownership of 12,845,240 shares of Common Stock, representing 7.01% of the class. The filing states Vanguard Capital Management exercises sole dispositive power over 12,845,240 shares and sole voting power over 1,554,511 shares. The filing notes affiliates and managed funds are included "in accordance with SEC Release No. 34-39538 (January 12, 1998)".
Regency Centers Corp: Vanguard Capital Management reported beneficial ownership of 12,845,240 shares of Common Stock, representing 7.01% of the class. The filing states Vanguard Capital Management exercises sole dispositive power over 12,845,240 shares and sole voting power over 1,554,511 shares. The filing notes affiliates and managed funds are included "in accordance with SEC Release No. 34-39538 (January 12, 1998)".
Regency Centers Corp reported a Schedule 13G filing showing Vanguard Portfolio Management beneficially owns 15,010,830 shares of Common Stock, representing 8.19% of the class. The filing lists 21,916 shares with sole voting power and states dispositive power over all 15,010,830 shares. The filing is signed by Ashley Grim on 04/29/2026.
Regency Centers Corp reported a Schedule 13G filing showing Vanguard Portfolio Management beneficially owns 15,010,830 shares of Common Stock, representing 8.19% of the class. The filing lists 21,916 shares with sole voting power and states dispositive power over all 15,010,830 shares. The filing is signed by Ashley Grim on 04/29/2026.
Regency Centers Corporation registers up to 100,000 shares of Common Stock under its Dividend Reinvestment and Stock Purchase Plan. This prospectus supplement describes the Plan that permits existing shareholders to reinvest cash dividends and make optional cash purchases of Common Stock, and it relates to up to 100,000 shares to be offered for purchase under the Plan. The supplement notes the Plan may purchase shares directly from the company or in the open market and states the last reported sale price on April 9, 2026 was $78.35.
Regency Centers Corporation registers up to 100,000 shares of Common Stock under its Dividend Reinvestment and Stock Purchase Plan. This prospectus supplement describes the Plan that permits existing shareholders to reinvest cash dividends and make optional cash purchases of Common Stock, and it relates to up to 100,000 shares to be offered for purchase under the Plan. The supplement notes the Plan may purchase shares directly from the company or in the open market and states the last reported sale price on April 9, 2026 was $78.35.
Regency Centers Corp Executive Chairman Martin E. Stein Jr. reported indirect transactions in the company’s common stock. On March 10 and March 11, the Joan W. Newton 2019 Revocable Trust, after receiving shares from The Regency Group II partnership where he is a general partner, sold 129,490 and 38,000 shares in open-market trades at weighted average prices of $78.334 and $77.2139 per share, totaling 167,490 shares sold. Separately, an irrevocable trust associated with him acquired 6,460 shares as a grant or award. Following these transactions, he continues to hold a significant stake, including 272,133 shares held directly and additional indirect holdings of 24,201, 110,263, and 4,000 shares through various trusts and a family-controlled corporation.
Regency Centers Corp Executive Chairman Martin E. Stein Jr. reported indirect transactions in the company’s common stock. On March 10 and March 11, the Joan W. Newton 2019 Revocable Trust, after receiving shares from The Regency Group II partnership where he is a general partner, sold 129,490 and 38,000 shares in open-market trades at weighted average prices of $78.334 and $77.2139 per share, totaling 167,490 shares sold. Separately, an irrevocable trust associated with him acquired 6,460 shares as a grant or award. Following these transactions, he continues to hold a significant stake, including 272,133 shares held directly and additional indirect holdings of 24,201, 110,263, and 4,000 shares through various trusts and a family-controlled corporation.
Martin E. Stein Jr. submitted a Form 144 notice reporting a proposed sale of 10,000 shares of Common Stock on 02/20/2026 with an indicated gross amount of $763,001.00. The filing identifies the shares as founders shares and lists a broker, BofA Securities, Inc..
Martin E. Stein Jr. submitted a Form 144 notice reporting a proposed sale of 10,000 shares of Common Stock on 02/20/2026 with an indicated gross amount of $763,001.00. The filing identifies the shares as founders shares and lists a broker, BofA Securities, Inc..
HERMAN MICHAEL R reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp reported that Senior VP and General Counsel Michael R. Herman received a grant of 7,215 shares of restricted stock on March 4, 2026. The award was granted at a price of $0.00 per share as part of his equity compensation.
All 7,215 shares are held as direct ownership after the transaction. According to the terms, the restricted shares vest in four equal installments of 25% each year, beginning on March 4, 2027.
HERMAN MICHAEL R reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp reported that Senior VP and General Counsel Michael R. Herman received a grant of 7,215 shares of restricted stock on March 4, 2026. The award was granted at a price of $0.00 per share as part of his equity compensation.
All 7,215 shares are held as direct ownership after the transaction. According to the terms, the restricted shares vest in four equal installments of 25% each year, beginning on March 4, 2027.
REGENCY CENTERS CORP Principal Accounting Officer Terah L. Devereaux received a grant of 3,173 restricted stock shares. The Form 4 reports this as an acquisition awarded on March 4, 2026 at a stated price of $0.00 per share.
The award vests over time, with 25% of the restricted stock scheduled to vest each year beginning on March 4, 2027. Following this grant, Devereaux is reported as directly owning 3,173 shares related to this award.
REGENCY CENTERS CORP Principal Accounting Officer Terah L. Devereaux received a grant of 3,173 restricted stock shares. The Form 4 reports this as an acquisition awarded on March 4, 2026 at a stated price of $0.00 per share.
The award vests over time, with 25% of the restricted stock scheduled to vest each year beginning on March 4, 2027. Following this grant, Devereaux is reported as directly owning 3,173 shares related to this award.